Home > News > From Flameout to Bargain
July 8th, 2004
From Flameout to Bargain
The stock of biopharmaceutical and Merrill Lynch (NYSE: MER) Nanotech Index (AMEX: NNZ) member Flamel Technologies (Nasdaq: FLML) has declined more than 50% since hitting a $43.60 all-time high in September. The stock, down 11% today on no discernible news, is not matching the 20% increase, since May, of its index peers. Although the recent stock flameout might be an indication of trouble, a closer look reveals a lot to like.
Harris & Harris Group Reports Financial Statements as of December 31, 2014 and Posts Annual Letter to Shareholders on Website March 17th, 2015
Aspen Aerogels, Inc. Schedules Fourth Quarter and Fiscal 2014 Earnings Release and Conference Call for February 26, 2015 February 11th, 2015
Arrowhead to Report Fiscal 2015 First Quarter Financial Results February 2nd, 2015
Graphenea sales more than double in 2014 January 29th, 2015